{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:27:57Z","timestamp":1791556077746,"version":"4.3.4"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","award":["2022.00586"],"award-info":[{"award-number":["2022.00586"]}],"id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","award":["292\/16"],"award-info":[{"award-number":["292\/16"]}],"id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005032","name":"Funda\u00e7\u00e3o Bial","doi-asserted-by":"publisher","award":["UIDB\/00645\/20209"],"award-info":[{"award-number":["UIDB\/00645\/20209"]}],"id":[{"id":"10.13039\/501100005032","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FCT-IF\/00787\/2014"],"award-info":[{"award-number":["FCT-IF\/00787\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["FP7-PEOPLE-2013-CIG 631952"],"award-info":[{"award-number":["FP7-PEOPLE-2013-CIG 631952"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LISBOA-01\\u20130145-FEDER-030907"],"award-info":[{"award-number":["LISBOA-01\\u20130145-FEDER-030907"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jpsychires.2024.06.050","type":"journal-article","created":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T11:23:08Z","timestamp":1719660188000},"page":"256-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["An exploration of blood-based biomarkers of negative symptoms of psychosis in men"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-9446","authenticated-orcid":false,"given":"Alexandra","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9926-3887","authenticated-orcid":false,"given":"Henrique Castro","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-9617","authenticated-orcid":false,"given":"Sara","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1793-4443","authenticated-orcid":false,"given":"Vasco","family":"Diogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Brissos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-5178","authenticated-orcid":false,"given":"Jo\u00e3o Gama","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2024.06.050_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/schbul\/sbab148","article-title":"Two factors, five factors, or both? External validation studies of negative symptom dimensions in schizophrenia","volume":"48","author":"Ahmed","year":"2022","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10928-008-9094-4","article-title":"Likelihood based approaches to handling data below the quantification limit using NONMEM VI","volume":"35","author":"Ahn","year":"2008","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S1516-44462000000300003","article-title":"Mini International Neuropsychiatric Interview (MINI): valida\u00e7\u00e3o de entrevista breve para diagn\u00f3stico de transtornos mentais","volume":"22","author":"Amorim","year":"2000","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.schres.2019.04.005","article-title":"Validation of the brief negative symptom scale and its association with functioning","volume":"208","author":"Ang","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/schbul\/sbz016","article-title":"Reduced DNA methylation of the oxytocin receptor gene is associated with anhedonia-asociality in women with recent-onset schizophrenia and ultra-high risk for psychosis","volume":"45","author":"Bang","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2015.04.030","article-title":"Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis","volume":"166","author":"Barbero","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/eip.12873","article-title":"Association between anti-thyroid antibodies and negative symptoms in early psychosis","volume":"14","author":"Barbero","year":"2020","journal-title":"Early Interv Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib9","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/oxfordjournals.schbul.a007141","article-title":"Aggregability of red blood cells of schizophrenia patients with negative syndrome is selectively enhanced","volume":"30","author":"Barshtein","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib10","doi-asserted-by":"crossref","first-page":"e335","DOI":"10.1038\/tp.2013.110","article-title":"A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia","volume":"3","author":"Bentsen","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.plefa.2012.05.005","article-title":"Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells","volume":"87","author":"Bentsen","year":"2012","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib12","doi-asserted-by":"crossref","first-page":"H222","DOI":"10.1152\/ajpheart.2001.280.1.H222","article-title":"Effect of erythrocyte aggregation on velocity profiles in venules","volume":"280","author":"Bishop","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/wps.20375","article-title":"A network theory of mental disorders","volume":"16","author":"Borsboom","year":"2017","journal-title":"World Psychiatr. : off. J. World Psychiatric Assoct. (WPA)"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00127-011-0412-6","article-title":"The Portuguese version of the Personal and Social Performance Scale (PSP): reliability, validity, and relationship with cognitive measures in hospitalized and community schizophrenia patients","volume":"47","author":"Brissos","year":"2012","journal-title":"Soc. Psychiatr. Psychiatr. Epidemiol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib15","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms23073636","article-title":"Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the immune system and diseases","volume":"23","author":"Buonacera","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.psychres.2018.02.002","article-title":"Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: evidence for early association between inflammation and psychosis","volume":"262","author":"Bustan","year":"2018","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib17","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/schbul\/sbaa129","article-title":"The latent structure of negative symptoms in individuals with attenuated psychosis syndrome and early psychosis: support for the 5 consensus domains","volume":"47","author":"Chang","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib18","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1001\/jama.1992.03480090092034","article-title":"The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis","volume":"267","author":"Chrousos","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2017.03.045","article-title":"Elevated clozapine levels associated with infection: a systematic review","volume":"192","author":"Clark","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/wps.20087","article-title":"The RDoC framework: facilitating transition from ICD\/DSM to dimensional approaches that integrate neuroscience and psychopathology","volume":"13","author":"Cuthbert","year":"2014","journal-title":"World Psychiatr. : off. J. World Psychiatric Assoct. (WPA)"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.14417\/lp.713","article-title":"Estudo de propriedades psicom\u00e9tricas do Question\u00e1rio de Trauma de Inf\u00e2ncia \u2013 Vers\u00e3o breve numa amostra portuguesa n\u00e3o cl\u00ednica","volume":"11","author":"Dias","year":"2014","journal-title":"Laborat\u00f3rio de Psicologia"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.psychres.2011.06.019","article-title":"Insight and negative symptoms as predictors of functioning in a work setting in patients with schizophrenia","volume":"189","author":"Erickson","year":"2011","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainres.2013.11.008","article-title":"Intranasal oxytocin effects on social cognition: a critique","author":"Evans","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155631","article-title":"Peripheral Immune Cell Populations Associated with Cognitive Deficits and Negative Symptoms of Treatment-Resistant Schizophrenia","volume":"11","author":"Fernandez-Egea","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib24","doi-asserted-by":"crossref","first-page":"179s","DOI":"10.1111\/j.1469-445X.2000.tb00022.x","article-title":"Diurnal rhythms in neurohypophysial function","volume":"85","author":"Forsling","year":"2000","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.euroneuro.2013.10.017","article-title":"Negative symptoms of schizophrenia: clinical features, relevance to real world functioning and specificity versus other CNS disorders","volume":"24","author":"Foussias","year":"2014","journal-title":"Eur. Neuropsychopharmacol : J. European College Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.700747","article-title":"Real-World functioning in patients with schizophrenia: beyond negative and cognitive symptoms","volume":"12","author":"Garc\u00eda-Portilla","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib27","first-page":"70","article-title":"The psychiatric phenotype of anti-NMDA receptor encephalitis","volume":"31","author":"Gibson","year":"2019","journal-title":"J. Neuroparasitol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042146","article-title":"Oxytocin in schizophrenia: pathophysiology and implications for future treatment","volume":"22","author":"Goh","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.00046","article-title":"Inflammation and Negative Symptoms of Schizophrenia: Implications for Reward Processing and Motivational Deficits","volume":"11","author":"Goldsmith","year":"2020","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.schres.2009.07.004","article-title":"The importance of cross-sectional remission in schizophrenia for long-term outcome: a clinical prospective study","volume":"115","author":"Helldin","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fpsyt.2020.00276","article-title":"Functional Neuroimaging in Psychiatry\u2014Aiding in Diagnosis and Guiding Treatment. What the American Psychiatric Association Does Not Know","volume":"11","author":"Henderson","year":"2020","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fpsyt.2019.00131","article-title":"Autoimmune diseases and psychotic disorders","volume":"10","author":"Jeppesen","year":"2019","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib32","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1017\/neu.2014.20","article-title":"Oxytocin and vasopressin levels are decreased in the plasma of male schizophrenia patients","volume":"26","author":"Jobst","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000325912","article-title":"The negative symptoms of schizophrenia: category or continuum?","volume":"44","author":"Kaiser","year":"2011","journal-title":"Psychopathology"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.schres.2018.12.017","article-title":"Neutrophil-to-lymphocyte ratio in schizophrenia: a systematic review and meta-analysis","volume":"206","author":"Karageorgiou","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib35","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17470910802319710","article-title":"Sharing secrets: oxytocin and trust in schizophrenia","volume":"4","author":"K\u00e9ri","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17470910802319710","article-title":"Sharing secrets: oxytocin and trust in schizophrenia","volume":"4","author":"K\u00e9ri","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/schbul\/sbq059","article-title":"The brief negative symptom scale: psychometric properties","volume":"37","author":"Kirkpatrick","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib39","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2016.01.036","article-title":"Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: a prospective 1-year follow-up study","volume":"171","author":"Labad","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17674-7","article-title":"A comparison of methods to measure central and peripheral oxytocin concentrations in human and non-human primates","volume":"7","author":"Lefevre","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-37846-y","article-title":"Altered neutrophil-to-lymphocyte ratio in patients with non-affective first episode psychosis and its relationship with symptom severity and cognitive impairment","volume":"13","author":"Leung","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1745017901915010058","article-title":"Sex-related differences in plasma oxytocin levels in humans","volume":"15","author":"Marazziti","year":"2019","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib43","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/15622975.2019.1583371","article-title":"Neutrophil-lymphocyte ratio, monocyte-lymphocyte ratio and platelet-lymphocyte ratio in non-affective psychosis: a meta-analysis and systematic review","volume":"21","author":"Mazza","year":"2020","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/schbul\/sbv133","article-title":"Levels of red blood cell fatty acids in patients with psychosis, their unaffected siblings, and healthy controls","volume":"42","author":"Medema","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib46","article-title":"Thyroid hormones in persons with schizophrenia: a systematic review and meta-analysis","volume":"111","author":"Misiak","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0028-2243(81)90077-0","article-title":"Plasma oxytocin concentrations during the menstrual cycle","volume":"12","author":"Mitchell","year":"1981","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib48","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15622970802264606","article-title":"Standardised rating scales in Psychiatry: methodological basis, their possibilities and limitations and descriptions of important rating scales","volume":"10","author":"M\u00f6ller","year":"2009","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fnbeh.2014.00343","article-title":"Homocysteine levels in schizophrenia and affective disorders\u2014focus on cognition","volume":"8","author":"Moustafa","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib50","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/schbul\/sbt154","article-title":"Meta-analyses of blood homocysteine levels for gender and genetic association studies of the MTHFR C677T polymorphism in schizophrenia","volume":"40","author":"Nishi","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib51","series-title":"Vitamins and Hormones, Thyroid Hormone","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/bs.vh.2017.05.005","article-title":"Chapter thirteen - thyroid hormone in the CNS: contribution of neuron\u2013glia interaction","author":"Noda","year":"2018"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib52","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00406-015-0634-9","article-title":"Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"266","author":"Oya","year":"2016","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2022.110669","article-title":"Cerebral blood flow in schizophrenia: a systematic review and meta-analysis of MRI-based studies","volume":"121","author":"Percie du Sert","year":"2023","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib55","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.pnpbp.2008.09.009","article-title":"Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia","volume":"32","author":"Petronijevi\u0107","year":"2008","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib56","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10673220390264258","article-title":"Biochemical alterations of erythrocytes as an indicator of mental disorders: an overview","volume":"11","author":"Ponizovsky","year":"2003","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib57","doi-asserted-by":"crossref","first-page":"84","DOI":"10.31211\/rpics.2021.7.1.210","article-title":"Psychometric properties of the raven's standard progressive matrices in a Portuguese sample","volume":"7","author":"Queiroz-Garcia","year":"2021","journal-title":"Revista Portuguesa de Investiga\u00e7\u00e3o Comportamental e Social"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2012.01.015","article-title":"Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data","volume":"137","author":"Rabinowitz","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib59","doi-asserted-by":"crossref","first-page":"73","DOI":"10.17575\/rpsicol.v25i1.280","article-title":"Escalas de medi\u00e7\u00e3o do Quociente de Empatia\/Sistematiza\u00e7\u00e3o: Um ensaio de valida\u00e7\u00e3o para a popula\u00e7\u00e3o portuguesa","volume":"25","author":"Rodrigues","year":"1969","journal-title":"Psicologia"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.schres.2010.09.014","article-title":"Peripheral oxytocin is associated with reduced symptom severity in schizophrenia","volume":"124","author":"Rubin","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib61","doi-asserted-by":"crossref","first-page":"898","DOI":"10.2466\/08.21.28.PR0.111.6.898-904","article-title":"The emotional contagion scale: factor structure and psychometric properties in a Portuguese sample","volume":"111","author":"Rueff-Lopes","year":"2012","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104979","article-title":"Thirty years of research on negative symptoms of schizophrenia: A scientometric analysis of hotspots, bursts, and research trends","volume":"144","author":"Sabe","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib62","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ijnp\/pyab020","article-title":"Intranasal oxytocin for negative symptoms of schizophrenia: systematic review, meta-analysis, and dose-response meta-analysis of randomized controlled trials","volume":"24","author":"Sabe","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yhbeh.2004.10.002","article-title":"Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women","volume":"47","author":"Salonia","year":"2005","journal-title":"Horm. Behav."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib64","first-page":"1","article-title":"The European Portuguese version of the brief negative symptom scale","author":"Santos","year":"2023","journal-title":"Psychopathology"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.plefa.2010.07.001","article-title":"Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia","volume":"83","author":"Sethom","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib66","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12026-018-9030-7","article-title":"The link between schizophrenia and hypothyroidism: a population-based study","volume":"66","author":"Sharif","year":"2018","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib67","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/JCP.10r06823","article-title":"Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis","volume":"73","author":"Sommer","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib68","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/oxfordjournals.humrep.a137484","article-title":"Plasma levels of oxytocin during the menstrual cycle, pregnancy and following treatment with HMG","volume":"6","author":"Stock","year":"1991","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib69","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/schbul\/sbx066","article-title":"A transdiagnostic review of negative symptom phenomenology and etiology","volume":"43","author":"Strauss","year":"2017","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.schres.2014.12.023","article-title":"Plasma oxytocin levels predict olfactory identification and negative symptoms in individuals with schizophrenia","volume":"162","author":"Strauss","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib71","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.schres.2015.12.014","article-title":"Negative symptoms in bipolar disorder and schizophrenia: a psychometric evaluation of the brief negative symptom scale across diagnostic categories","volume":"170","author":"Strauss","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.574375","article-title":"Deep learning-based human activity recognition for continuous activity and gesture monitoring for schizophrenia patients with negative symptoms","volume":"11","author":"Umbricht","year":"2020","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib73","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.schres.2017.12.016","article-title":"Monocyte activation detected prior to a diagnosis of schizophrenia in the US military new onset psychosis Project (MNOPP)","volume":"197","author":"Weber","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib74","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/13651501.2020.1810278","article-title":"Negative symptoms in schizophrenia, assessed by the brief negative symptom scale, self-evaluation of negative symptom scale, and social cognition: a gender effect","volume":"25","author":"W\u00f3jciak","year":"2021","journal-title":"Int. J. Psychiatr. Clin. Pract."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib75","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.euroneuro.2016.11.012","article-title":"Adjunctive minocycline for schizophrenia: a meta-analysis of randomized controlled trials","volume":"27","author":"Xiang","year":"2017","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib76","article-title":"Predicting real-world functioning in schizophrenia: the relative Contributions of neurocognition, functional capacity, and negative symptoms","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib77","first-page":"189","article-title":"Red blood cell intercellular interactions in oxidative stress states","volume":"21","author":"Yedgar","year":"1999","journal-title":"Clin. Hemorheol. Microcirc."},{"key":"10.1016\/j.jpsychires.2024.06.050_bib78","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000073578","article-title":"The red blood cell in vascular occlusion","volume":"32","author":"Yedgar","year":"2002","journal-title":"Pathophysiol. Haemostasis Thrombosis"},{"key":"10.1016\/j.jpsychires.2024.06.050_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2020.581061","article-title":"Neutrophil-to-Lymphocyte ratio is independently associated with severe psychopathology in schizophrenia and is changed by antipsychotic administration: a large-scale cross-sectional retrospective study","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Psychiatr."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624003789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395624003789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:09:26Z","timestamp":1777421366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395624003789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":81,"alternative-id":["S0022395624003789"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.06.050","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An exploration of blood-based biomarkers of negative symptoms of psychosis in men","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2024.06.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}